These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 14527906)

  • 1. Progression of gene hypermethylation in gallstone disease leading to gallbladder cancer.
    House MG; Wistuba II; Argani P; Guo M; Schulick RD; Hruban RH; Herman JG; Maitra A
    Ann Surg Oncol; 2003 Oct; 10(8):882-9. PubMed ID: 14527906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoter methylation profile in preneoplastic and neoplastic gallbladder lesions.
    García P; Manterola C; Araya JC; Villaseca M; Guzmán P; Sanhueza A; Thomas M; Alvarez H; Roa JC
    Mol Carcinog; 2009 Jan; 48(1):79-89. PubMed ID: 18543280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant promoter hypermethylation of multiple genes in gallbladder carcinoma and chronic cholecystitis.
    Takahashi T; Shivapurkar N; Riquelme E; Shigematsu H; Reddy J; Suzuki M; Miyajima K; Zhou X; Bekele BN; Gazdar AF; Wistuba II
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6126-33. PubMed ID: 15447999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microsatellite instability in preneoplastic and neoplastic lesions of the gallbladder.
    Roa JC; Roa I; Correa P; Vo Q; Araya JC; Villaseca M; Guzmán P; Schneider BG
    J Gastroenterol; 2005 Jan; 40(1):79-86. PubMed ID: 15692793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant hypermethylation of tumor suppressor genes in pancreatic endocrine neoplasms.
    House MG; Herman JG; Guo MZ; Hooker CM; Schulick RD; Lillemoe KD; Cameron JL; Hruban RH; Maitra A; Yeo CJ
    Ann Surg; 2003 Sep; 238(3):423-31; discussion 431-2. PubMed ID: 14501508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter methylation profile in gallbladder cancer.
    Roa JC; Anabalón L; Roa I; Melo A; Araya JC; Tapia O; de Aretxabala X; Muñoz S; Schneider B
    J Gastroenterol; 2006 Mar; 41(3):269-75. PubMed ID: 16699861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of promoter DNA hypermethylation of the cysteine dioxygenase 1 (CDO1) gene in primary gallbladder cancer and gallbladder disease.
    Igarashi K; Yamashita K; Katoh H; Kojima K; Ooizumi Y; Nishizawa N; Nishiyama R; Kawamata H; Tajima H; Kaizu T; Kumamoto Y; Watanabe M
    PLoS One; 2017; 12(11):e0188178. PubMed ID: 29161283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global and gene-specific DNA methylation pattern discriminates cholecystitis from gallbladder cancer patients in Chile.
    Kagohara LT; Schussel JL; Subbannayya T; Sahasrabuddhe N; Lebron C; Brait M; Maldonado L; Valle BL; Pirini F; Jahuira M; Lopez J; Letelier P; Brebi-Mieville P; Ili C; Pandey A; Chatterjee A; Sidransky D; Guerrero-Preston R
    Future Oncol; 2015; 11(2):233-49. PubMed ID: 25066711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines.
    Caca K; Feisthammel J; Klee K; Tannapfel A; Witzigmann H; Wittekind C; Mössner J; Berr F
    Int J Cancer; 2002 Feb; 97(4):481-8. PubMed ID: 11802210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional differences in gallbladder cancer pathogenesis: Insights from a multi-institutional comparison of tumor mutations.
    Narayan RR; Creasy JM; Goldman DA; Gönen M; Kandoth C; Kundra R; Solit DB; Askan G; Klimstra DS; Basturk O; Allen PJ; Balachandran VP; D'Angelica MI; DeMatteo RP; Drebin JA; Kingham TP; Simpson AL; Abou-Alfa GK; Harding JJ; O'Reilly EM; Butte JM; Matsuyama R; Endo I; Jarnagin WR
    Cancer; 2019 Feb; 125(4):575-585. PubMed ID: 30427539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor progression through epigenetic gene silencing of O(6)-methylguanine-DNA methyltransferase in human biliary tract cancers.
    Koga Y; Kitajima Y; Miyoshi A; Sato K; Kitahara K; Soejima H; Miyazaki K
    Ann Surg Oncol; 2005 May; 12(5):354-63. PubMed ID: 15915369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor suppressor gene hypermethylation as a predictor of gastric stromal tumor behavior.
    House MG; Guo M; Efron DT; Lillemoe KD; Cameron JL; Syphard JE; Hooker CM; Abraham SC; Montgomery EA; Herman JG; Brock MV
    J Gastrointest Surg; 2003 Dec; 7(8):1004-14; discussion 1014. PubMed ID: 14675710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic analysis of xanthogranulomatous cholecystitis: precancerous lesion of gallbladder cancer?
    Takada M; Horita Y; Okuda S; Okumoto S; Samizo M; Wada T; Kuroda Y; Maeda S
    Hepatogastroenterology; 2002; 49(46):935-7. PubMed ID: 12143246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific patterns of gene methylation in natural killer cell lymphomas : p73 is consistently involved.
    Siu LL; Chan JK; Wong KF; Kwong YL
    Am J Pathol; 2002 Jan; 160(1):59-66. PubMed ID: 11786399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular progression of promoter methylation in intraductal papillary mucinous neoplasms (IPMN) of the pancreas.
    House MG; Guo M; Iacobuzio-Donahue C; Herman JG
    Carcinogenesis; 2003 Feb; 24(2):193-8. PubMed ID: 12584167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
    Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
    Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers.
    Belinsky SA; Palmisano WA; Gilliland FD; Crooks LA; Divine KK; Winters SA; Grimes MJ; Harms HJ; Tellez CS; Smith TM; Moots PP; Lechner JF; Stidley CA; Crowell RE
    Cancer Res; 2002 Apr; 62(8):2370-7. PubMed ID: 11956099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate stem cell antigen, a presumable organ-dependent tumor suppressor gene, is down-regulated in gallbladder carcinogenesis.
    Ono H; Hiraoka N; Lee YS; Woo SM; Lee WJ; Choi IJ; Saito A; Yanagihara K; Kanai Y; Ohnami S; Chiwaki F; Sasaki H; Sakamoto H; Yoshida T; Saeki N
    Genes Chromosomes Cancer; 2012 Jan; 51(1):30-41. PubMed ID: 21936014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of p16INK4a and RASSF1A promoter hypermethylation in prognosis of patients with resectable non-small cell lung cancer.
    Wang J; Lee JJ; Wang L; Liu DD; Lu C; Fan YH; Hong WK; Mao L
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6119-25. PubMed ID: 15447998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WNT inhibitory factor 1 promoter hypermethylation is an early event during gallbladder cancer tumorigenesis that predicts poor survival.
    Lin B; Hong H; Jiang X; Li C; Zhu S; Tang N; Wang X; She F; Chen Y
    Gene; 2017 Jul; 622():42-49. PubMed ID: 28438695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.